Imperial College London Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
University of Dundee Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Cardiff University Featured PhD Programmes
"career"×
10 miles

Pharmacology / Toxicology (career) PhD Projects, Programs & Scholarships

We have 38 Pharmacology / Toxicology (career) PhD Projects, Programs & Scholarships

  • "career" ×
  • Pharmacology / Toxicology×
  • clear all
Order by 
Showing 1 to 10 of 38
  International PhD Programme in Biomedical Sciences Center for Genomic Regulation (CRG), Barcelona

Funding Type

PhD Type

Apply now to boost your scientific career in a center of excellence, backed by first class core facilities and a broad training portfolio in our multidisciplinary, international community.
  MRC DiMeN Doctoral Training Partnership: Combining senolytic treatment with exercise to prevent the development of sarcopenia
  Dr S Miwa, Prof A McArdle, Prof T von Zglinicki
Application Deadline: 6 January 2020

Funding Type

PhD Type

Muscle loss with ageing (sarcopenia) is a major contributor to frailty and loss of independency in older people. Exercise intervention can improve muscle function, but is not able to prevent age-associated muscle loss.
  MRC DiMeN Doctoral Training Partnership: Drug discovery to control C. difficile infections by targeting sporulation
  Dr P Salgado, Dr J Hubbard
Application Deadline: 6 January 2020

Funding Type

PhD Type

Interested in a PhD studying antibiotic resistant bacteria and explore new ways to treat drug-resistant infections? In this PhD, you will use a range of biochemistry, biophysical and structural techniques, together with molecular biology, genetics, and microbiology approached to develop new therapeutics targeting C.
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard
Applications accepted all year round

Funding Type

PhD Type

Targeted therapy has had profound impact on outcomes for cancer patients.
  Metabolic Reprogramming in Liver Cancer: delineating the role of reactive oxygen species (ROS) in tumour development
  Prof T. Tiganis
Applications accepted all year round

Funding Type

PhD Type

The Tiganis Laboratory is seeking a highly enthusiastic student to conduct research in cancer metabolism and obesity-associated liver cancer.
  RNA Methylation in normal and malignant blood development
  Dr L. Kats
Applications accepted all year round

Funding Type

PhD Type

As is the case with DNA and histones, RNA can also be modified and indeed more than 100 chemical groups that decorate all four canonical RNA nucleotides have been described.
  Fostering development of ‘smart’, responsive therapeutics against cancer-related microRNAs.
  Dr E Bichenkova, Prof D Clarke, Dr H Aojula
Applications accepted all year round

Funding Type

PhD Type

Short functional non-coding microRNAs are implicated in many types of cancer, and thus can be used as biological targets for development of more selective and powerful anticancer therapies.
  MRC DiMeN Doctoral Training Partnership: Understanding zinc-dependent regulation of TRPC5 channels and its role in diabetes
  Dr R.S. Bon, Dr S Muench, Dr P Sukumar
Application Deadline: 6 January 2020

Funding Type

PhD Type

TRPC5 ion channels are emerging drug targets, for example for CNS disorders, renal disease, cancer and cardiovascular disease (Cells 2018, 7, pii.
  MRC DiMeN Doctoral Training Partnership: Design and Optimisation of Red/NIR Fluorescent Dyes for the Assessment of Antimicrobial Susceptibility
  Prof D Kell, Dr G Nixon
Application Deadline: 6 January 2020

Funding Type

PhD Type

The current anti-microbial resistance (AMR) crisis is well documented and the need for a very rapid antibiotic susceptibility test is key to preventing mis-diagnosis and subsequent mis-prescribing.
  MRC DiMeN Doctoral Training Partnership: Liquid biopsy of the liver to improve molecular targeted cancer therapy
  Prof C Goldring, Prof F Falciani, Dr A Chadwick, Dr M Cross
Application Deadline: 6 January 2020

Funding Type

PhD Type

Molecular targeted therapies have revolutionised oncology. However, whilst patient life-expectancy is improving, these therapies carry a risk of causing damage to healthy tissues in the body, especially to the liver.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.